ID: ALA2261623

Max Phase: Preclinical

Molecular Formula: C16H13N3O3

Molecular Weight: 295.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOc1ccc(NC2=CC(=O)c3ncncc3C2=O)cc1

Standard InChI:  InChI=1S/C16H13N3O3/c1-2-22-11-5-3-10(4-6-11)19-13-7-14(20)15-12(16(13)21)8-17-9-18-15/h3-9,19H,2H2,1H3

Standard InChI Key:  PVJXWANQYODFIX-UHFFFAOYSA-N

Associated Targets(Human)

HCT-15 51914 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

XF498 12972 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-MEL-2 46422 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-OV-3 52876 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 295.30Molecular Weight (Monoisotopic): 295.0957AlogP: 2.25#Rotatable Bonds: 4
Polar Surface Area: 81.18Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.67CX Basic pKa: CX LogP: 1.07CX LogD: 1.07
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.93Np Likeness Score: -0.36

References

1. Ryu C, Yi Y, Choi IH, Chae MJ, Han J, Jung O, Lee C.  (2004)  Synthesis and Cytotoxic Activity of 6-(Substituted-Phenyl)Amino-5,8-Quinazolinediones,  13  (5): [10.1007/s00044-004-0032-8]

Source